Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

Morphic Holding, Inc. Common Stock (MORF)

Pharmaceutical Preparations

http://www.morphictx.com

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.

35 GATEHOUSE DRIVE A2
WALTHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/27/2019

Market Cap

2,862,305,653

Shares Outstanding

49,740,000

Weighted SO

49,742,966

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

ACLX --.--%

VTYX --.--%

IMCR --.--%

PCVX --.--%

DICE --.--%

ETNB --.--%

MDGL --.--%

PLRX --.--%

Beta

1.4900

Last Div

0.0000

Range

19.345-57.0

Chg

0.0200

Avg Vol

2453038

Mkt Cap

2862305653

Exch

NASDAQ

Country

US

Phone

781 996 0955

DCF Diff

55.9196

DCF

1.0704

Div Yield

0.0000

P/S

-47.5182

EV Multiple

-13.2664

P/FV

4.6164

Div Yield %

0.0000

P/E

-15.8761

PEG

-1.4183

Payout

0.0000

Current Ratio

24.1274

Quick Ratio

24.1274

Cash Ratio

1.9155

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

2290.1069

CCC

-2290.1069

Gross Margin

1.0186

Op Margin

3.5364

Pretax Margin

2.9766

Net Margin

2.9854

Eff Tax Rate

-0.0020

ROA

-0.2783

ROE

-0.2662

ROCE

-0.3438

NI/EBT

1.0030

EBT/EBIT

0.8417

EBIT/Rev

3.5364

Debt Ratio

0.0051

D/E

0.0054

LT Debt/Cap

0.0019

Total Debt/Cap

0.0053

Int Coverage

-63.4165

CF/Debt

-41.0916

Equity Multi

1.0447

Rec Turnover

0.0000

Pay Turnover

0.1594

Inv Turnover

0.0000

FA Turnover

-10.6707

Asset Turnover

-0.0932

OCF/Share

-2.7208

FCF/Share

-2.7477

Cash/Share

12.5434

OCF/Sales

2.2628

FCF/OCF

1.0099

CF Coverage

-41.0916

ST Coverage

-63.0439

CapEx Coverage

-101.1886

Div&CapEx Cov

-101.1886

P/BV

4.6164

P/B

4.6164

P/S

-47.5182

P/E

-15.8761

P/FCF

-20.7944

P/OCF

-20.9459

P/CF

-20.9459

PEG

-1.4183

P/S

-47.5182

EV Multiple

-13.2664

P/FV

4.6164

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 28, 20:00 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses

Revenue Product Segmentation